E, G., A, G., A, C., FM, P., ER, G., I, P., . . . L, L. (2026). Independent validation of the International Metabolic Prognostic Index (CAR-IMPI) in patients with aggressive diffuse large B-cell lymphoma treated with CAR-T. British journal of haematology. https://doi.org/10.1111/bjh.70846
Chicago Style (17th ed.) CitationE, Galli, et al. "Independent Validation of the International Metabolic Prognostic Index (CAR-IMPI) in Patients with Aggressive Diffuse Large B-cell Lymphoma Treated with CAR-T." British Journal of Haematology 2026. https://doi.org/10.1111/bjh.70846.
MLA (9th ed.) CitationE, Galli, et al. "Independent Validation of the International Metabolic Prognostic Index (CAR-IMPI) in Patients with Aggressive Diffuse Large B-cell Lymphoma Treated with CAR-T." British Journal of Haematology, 2026, https://doi.org/10.1111/bjh.70846.